Australia markets closed

Cynata Therapeutics Limited (CYP.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.3350+0.0050 (+1.52%)
At close: 04:10PM AEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Operating expenses
Research development
5,920
12,394
8,825
3,778
-
Selling general and administrative
3,153
3,232
4,060
4,494
2,940
Total operating expenses
16,655
16,543
13,838
9,080
10,512
Operating income or loss
-16,655
-16,543
-13,838
-9,080
-10,512
Total other income/expenses net
2,573
1,912
8,328
1,298
6,731
Income before tax
-13,646
-14,277
-5,445
-7,690
-3,639
Income tax expense
0
0
0
0
0
Income from continuing operations
-13,646
-14,277
-5,445
-7,690
-3,639
Net income
-13,646
-14,277
-5,445
-7,690
-3,639
Net income available to common shareholders
-13,646
-14,277
-5,445
-7,690
-3,639
Basic EPS
-0.10
-0.10
-0.04
-0.06
-0.03
Diluted EPS
-0.10
-0.10
-0.04
-0.06
-0.03
Basic average shares
145,092
145,092
143,277
130,427
104,822
Diluted average shares
145,092
145,092
143,277
130,427
104,822